Login to Your Account

'Cirius' money funds NASH hopeful with $40M series A

By Marie Powers
News Editor

Tuesday, April 11, 2017

Cirius Therapeutics Inc. completed a series A financing of up to $40 million – drawing down $30 million in the initial tranche, according to an SEC filing – in a round that was co-led by Frazier Healthcare Partners and Novo A/S.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription